Oncogenuity, Inc.

Partnering

A Network of Experts

Our Partners

Oncogenuity has teamed up with researchers at Columbia University to develop a broad platform capable of treating genetically driven cancers, genetic diseases, and coronaviruses using oligonucleotides (ONCOlogues). The ONCOlogue technology comes from the labs of Gary Schwartz, M.D., Division Chief, Hematology/Oncology, and Jeffrey Rothman, M.D., Ph.D., Assistant Professor of Medicine.

Forging the Future of Drug Discovery

We welcome partnerships with researchers and established medical companies to bring life-improving technologies to patients. If you have an idea for developing a transformative biopharmaceutical solution or would like to partner with us on any of our programs, please contact us.

Connect with Our Partnership Team